Posted on: 03 November, 2025
Researchers within the Kolling Institute will shortly have the chance to strengthen their genomics capabilities, with AGRF – the Australian Genome Research Facility - establishing a laboratory within the institute.
The new lab is part of an exciting partnership between AGRF, the University of Sydney and the Kolling which will see a specialised team and cutting-edge technology located within the ins.....
Read more
Category: Research Excellence, World-leading technology
Posted on: 12 November, 2024
Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There's a focus too on the first steps towards gene therapy for Meniere's disease, the latest research into treatments for dementia and.....
Read more
Category: New Treatment, Newsletters, Research Excellence
Posted on: 05 September, 2019
Congratulations to Professor David Hunter who’s received a prestigious University of Sydney Vice Chancellor’s award for outstanding research.
The Kolling researcher and rheumatology clinician is regarded as the world’s leading expert in osteoarthritis.
Professor Hunter’s research has had a significant and lasting impact in the field of osteoarthritis, influencing clinical practice and access to ev.....
Read more
Category: Awards, New Treatment
Posted on: 22 July, 2019
The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase.
Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain.
RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the disease to indivi.....
Read more
Category: New Treatment